140. Dorabe syndrome
83 clinical trials,   54 drugs   (DrugBank: 13 drugs),   48 drug target genes,   62 drug target pathways
Searched query = "Dorabe syndrome", "Dravet syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04442295 (ClinicalTrials.gov) | June 3, 2020 | 8/6/2020 | An Open-Label Study to Investigate the Safety of Single Ascending Doses in Children and Adolescents With Dravet Syndrome | An Open-Label Study to Investigate the Safety and Pharmacokinetics of Single Ascending Doses of Antisense Oligonucleotide STK-001 in Children and Adolescents With Dravet Syndrome | Dravet Syndrome | Drug: STK-001 | Stoke Therapeutics, Inc | NULL | Recruiting | 2 Years | 18 Years | All | 48 | Phase 1;Phase 2 | United States |